Figure 1 — Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)

Navigate

Research Paper|Volume 8, Issue 8|pp. 1593–1606

Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)

Back to articleFigure 1(1 of 11)

100%

Figure 1.Bedaquiline: Structure and ActivityBedaquiline, also known as TMC207 and R207910, is a first-in-class diaryl-quinoline compound, that mechanistically inhibits the bacterial ATP-synthase.

Figure 1 — Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs) | Aging